23-valent pneumococcal polysaccharide vaccine (Beijing Luzhu Biopharmaceutical)

23价肺炎球菌多糖疫苗 （北京智飞绿竹生物制药有限公司）

Report date: 2025/10/15 17:32:35

Base Information

Drug Name23-valent pneumococcal polysaccharide vaccine (Beijing Luzhu Biopharmaceutical)
Drug Alias Name23-valent pneumococcal polysaccharide vaccine(Beijing Luzhu Biopharmaceutical)优威克
ClassificationVaccines > Vaccine type > Multivalent vaccineVaccines > Biological material > Bacterial vaccineVaccines > Application > Prophylactic vaccine +[5] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMeningitisOtitis MediaPneumonia +[6] 
Global Approved IndicationsPneumococcal Infections
Approved Indications in ChinaPneumococcal Infections
Original Approved Country/TerritoryMainland China
Original Approved Date2023/08/29
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBeijing Zhifei Lvzhu Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Zhifei Lvzhu Biopharmaceutical Co Ltd
Inactive CompaniesBeijing Lvzhu Biological Technology Co Ltd
Active IndicationsPneumococcal Infections
Inactive IndicationsMeningitisOtitis MediaPneumonia +[5] 

Other Information

ATC CodeN/A
Related LinksN/A